Lena Cook
Marburg An Der Lahn, HE 35033, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Deciphering the regulatory role of ADAM8 in the PDAC tumor microenvironment.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: November 05, 2025
The long non-coding RNA NEAT1 contributes to aberrant STAT3 signaling in pancreatic cancer and is regulated by a metalloprotease-disintegrin ADAM8/miR-181a-5p axis.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: September 30, 2024
Proteometabolomics of initial and recurrent glioblastoma highlights an increased immune cell signature with altered lipid metabolism.
Journal: Neuro-oncology
Published: October 26, 2023
A jack of all trades - ADAM8 as a signaling hub in inflammation and cancer.
Journal: The FEBS journal
Published: August 18, 2023
ADAM8-Dependent Extracellular Signaling in the Tumor Microenvironment Involves Regulated Release of Lipocalin 2 and MMP-9.
Journal: International journal of molecular sciences
Published: December 30, 2021
Discovery of Dimeric Arylsulfonamides as Potent ADAM8 Inhibitors.
Journal: ACS medicinal chemistry letters
Published: July 28, 2021
Extracellular Vesicle-Based Detection of Pancreatic Cancer.
Journal: Frontiers in cell and developmental biology
Published: April 20, 2021
ADAM8 signaling drives neutrophil migration and ARDS severity.
Journal: JCI insight
Published: March 25, 2021
Cohort Analysis of ADAM8 Expression in the PDAC Tumor Stroma.
Journal: Journal of personalized medicine
Published: January 26, 2021
Expression of the Metalloproteinase ADAM8 Is Upregulated in Liver Inflammation Models and Enhances Cytokine Release In Vitro.
Journal: Mediators of inflammation
Published: December 04, 2020
ADAM8 in invasive cancers: links to tumor progression, metastasis, and chemoresistance.
Journal: Clinical science (London, England : 1979)
Published: November 01, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026